• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHB2200076 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) Supplementary Application 2022-06-08 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2200077 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) Supplementary Application 2022-06-08 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2200072 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) Supplementary Application 2022-05-31 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHB2200071 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) Supplementary Application 2022-05-31 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2200296 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) New Drug Application 2022-05-10 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2200291 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) New Drug Application 2022-05-10 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd view
CXHL2100136 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) New Drug Application 2021-02-25 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2021-02-24 view
CXHL2100137 苹果酸Sitravatinib胶囊 sitravatinib malate Capsule Chemical Drugs(1) New Drug Application 2021-02-25 百济神州(苏州)生物科技有限公司 Baiji Shenzhou (Suzhou) Biotechnology Co Ltd In Review 2021-02-24 view